Obesity In America Advisory Board
Content for The Endocrine Society Weighs In: A Handbook on Obesity in America, was directed by an advisory board comprised of members of The Endocrine Society and The Hormone Foundation. The Board members represent the full scope of endocrinology, with specialties in clinical practice, research and academia. The primary objective of the Board is to improve awareness, understanding and appreciation of obesity and the role of endocrinology in obesity prevention, diagnosis and treatment. The The Endocrine Society Weighs In: A Handbook on Obesity in America 2004 Advisory Board includes:
E. Chester Ridgway, M.D., Past-President,
The Endocrine Society
In addition to his position as The
Endocrine Society’s 2003-2004
President, E. Chester “Chip” Ridgway, M.D., currently
serves as Professor of Medicine; Head, Division of Endocrinology,
Metabolism and
Diabetes; and Senior Associate Dean for Academic Affairs at the University
of Colorado Health Sciences Center. His clinical interest is in disorders
of the thyroid and pituitary glands, while his basic research focuses
on thyrotropin (TSH), the major regulator of the thyroid gland, and
glycoprotein
pituitary hormones by pituitary tumors. Dr. Ridgway received his
bachelor’s
degree from Dartmouth College in Hanover, NH, in 1964, and his medical
degree in 1968 from the University of Colorado Medical School in
Denver.
Robert B. Jaffe, M.D., President, The Hormone Foundation
Advisory Board Co-Chair
In addition to his position as The Hormone
Foundation’s President
and Co-Chair of the Advisory Board for The Endocrine Society
Weighs In: A Handbook on Obesity in America, Robert B. Jaffe,
M.D., is the Fred Gellert
Professor of Reproductive Medicine and Biology; former Director
of the Center for Reproductive Sciences; and past Chairman of the Department
of
Obstetrics, Gynecology and Reproductive Sciences at the University
of California, San Francisco. His clinical interests are women with hormonal
problems,
and his research involves regulation of the menstrual cycle, developmental
endocrinology and ovarian cancer. He is a board certified reproductive
endocrinologist and obstetrician gynecologist. Previously, he was
a Professor in the Department of Obstetrics and Gynecology at the University
of Michigan.
Dr. Jaffe received his bachelor’s degree from the University
of Michigan, his master's degree from the University of Colorado
in Denver,
and his
medical degree from the University of Michigan Medical School.
Glenn D. Braunstein, M.D., Advisory Board Co-Chair
Glenn D. Braunstein, M.D., currently serves as Chair of the Department
of Medicine at Cedars-Sinai Medical Center in Los Angeles and
is the James R. Klinenberg, M.D., Chair in Medicine. He is also
Vice
Chair
of the Department
of Medicine at the University of California, Los Angeles, School
of Medicine, where he serves as a Professor of Medicine, and
the Co-Chair
of the Advisory
Board for The Endocrine Society Weighs In: A Handbook on
Obesity in America. Dr. Braunstein is board certified in
internal medicine with
a subspecialty
of endocrinology, diabetes and metabolism. His research has been
primarily in the field of reproductive endocrinology and he is
Immediate Past-President of the Endocrinologic and Metabolic
Drugs Advisory Committee of the Food
and Drug Administration. Dr. Braunstein is also the Chair of
The Endocrine Society’s Media Advisory Committee. He earned
both his bachelor's and medical degrees from the University of
California, San Francisco.
George Bray, M.D.
George Bray, M.D., currently serves as Boyd Professor and Chief of Clinical
Obesity at Pennington Biomedical Research Center in Baton Rogue, LA.
His major research interests have been in obesity and diabetes at both
the experimental and clinical levels. He is a researcher for the Diabetes
Prevention Program (DPP) and Look AHEAD, two multi-center, National
Institutes of Health (NIH) funded trials looking at different aspects
of the relationship between weight management, obesity, diabetes and
overall health risk. Dr. Bray received his medical degree from Harvard
Medical School.
Daniel J. Drucker, M.D.
Daniel J. Drucker, M.D., is an Endocrinologist and Professor of Medicine
in the Division of Endocrinology, Department of Medicine at Toronto General
Hospital and the University of Toronto, where he also serves as Director
of the Banting and Best Diabetes Centre. Both a practicing physician
and an active researcher, Dr. Drucker received training in Internal Medicine
and Endocrinology from the Johns Hopkins Hospital in Baltimore and Toronto
General Hospital at the University of Toronto.
Barry J. Goldstein, M.D.,
Ph.D.
Barry J. Goldstein, M.D., Ph.D., is the
Director of the Division of Endocrinology, Diabetes and Metabolic Diseases
at Thomas Jefferson
University Hospital
and Professor of Medicine, Biochemistry and Molecular Pharmacology at
Jefferson Medical College of Thomas Jefferson University in Philadelphia.
Dr. Goldstein maintains active basic and clinical research programs that
target mechanisms and regulation of insulin signal transduction, especially
the pathophysiology of insulin-resistant disease states, including obesity
and Type 2 diabetes. Dr. Goldstein received a bachelor’s degree
with distinction from Cornell University where he concentrated in Biochemistry
and Genetics and graduated with honors from the Medical Scientist Training
Program (M.D./Ph.D. Biochemistry) of the University of Rochester School
of Medicine. His fellowship training was completed at Harvard Medical
School and the Joslin Diabetes Center in Boston.
Michael D. Jensen, M.D.
Michael D. Jensen, M.D., is a Professor of Medicine and a consultant
in the Division of Endocrinology, Diabetes and Metabolism at the Mayo
Clinic in Rochester, MN. Dr. Jensen is board certified in Internal Medicine,
Endocrinology and Metabolism, and Clinical Nutrition. His primary clinical
interests are obesity and diabetes mellitus, while his research involves
the study of obesity, body fat distribution, fatty acid and energy metabolism.
Dr. Jensen received his undergraduate medical degree from the University
of Missouri-Kansas City and received his Internal Medicine and subspecialty
training at the Mayo Clinic.
Francine R. Kaufman, M.D.
Francine R. Kaufman, M.D., currently serves as the head of the Center
for Diabetes, Endocrinology and Metabolism at the Children’s Hospital
of Los Angeles and is a Professor of Pediatrics at the Keck School of
Medicine at the University of Southern California. She is board certified
in Pediatrics and Pediatric Endocrinology by the American Board of Pediatrics.
Her research interests include the prevention and treatment of Type 1
and Type 2 diabetes in children and adolescents and she serves as the
study chair for the NIH STOPP-T2 trials, assessing treatment and prevention
strategies for Type 2 diabetes in pediatric subjects. After receiving
her medical degree from Chicago Medical School, Dr. Kaufman completed
her residency in Pediatrics and Pediatric Endocrinology at the Children’s
Hospital of Los Angeles.
Ellen W. Seely, M.D.
Ellen W. Seely, M.D., currently serves as Associate Professor of Medicine
at Harvard Medical School and Director of the Clinical Research, Endocrinology,
Diabetes and Hypertension Division at Brigham and Women's Hospital
in Boston. She is actively involved in research, teaching and clinical
care. Dr. Seely is a leader in patient-oriented research of the physiology
of blood pressure regulation in women during pregnancy and following
menopause. A graduate of Brown University, Dr. Seely received her medical
degree from Columbia University's College of Physicians and Surgeons,
and her internal medicine and endocrinology fellowship training at
Brigham and Women's Hospital.
Melissa K. Thomas, M.D., Ph.D.
Melissa K. Thomas, M.D., Ph.D., currently serves as a Clinical Assistant
in Medicine affiliated with the Molecular Endocrinology and Diabetes
Units at Massachusetts General Hospital (MGH) and as an Assistant Professor
of Medicine at Harvard Medical School. Dr. Thomas is actively involved
in health policy development and has served in national leadership
positions in the American Medical Association, The Endocrine Society
and the Accreditation
Council for Graduate Medical Education. Dr. Thomas's research program
in pancreatic beta-cell biology explores the development of novel therapies
to restore insulin production in patients with diabetes and she holds
multiple patents from research discoveries. Dr. Thomas completed clinical
training at MGH in Internal Medicine and in Endocrinology and research
training in the laboratories of Drs. Jackie Corbin (Vanderbilt) and
Joel Habener (Harvard).
Holly Wyatt, M.D.
Holly Wyatt, M.D., is an Assistant Professor in the Department of
Medicine, Division of Endocrinology, Metabolism and Diabetes at the
University
of Colorado Health Sciences Center, and currently serves as a physician
and clinical researcher at the Center for Human Nutrition. Dr. Wyatt's
research includes understanding energy and macronutrient balance in obese
individuals and individuals who are successfully maintaining weight loss
(reduced-obese). Dr. Wyatt received her bachelor’s degree from
the University of Texas and her medical degree from Baylor College of
Medicine in Houston.
